APO Research
Talk to an analyst

APO RESEARCH · REPORT

Livestock Foot and Mouth Disease (FMD) Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Livestock Foot and Mouth Disease (FMD) Vaccines Market Outlook and Growth Opportunities 2026

31 December 2025211 pages

Choose your research edition.

Industry ResearchLivestock Foot and Mouth Disease (FMD) Vaccines Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Livestock Foot and Mouth Disease (FMD) Vaccines Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Livestock Foot and Mouth Disease (FMD) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Livestock Foot and Mouth Disease (FMD) Vaccines Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Livestock Foot and Mouth Disease (FMD) Vaccines Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Livestock Foot and Mouth Disease (FMD) Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Livestock Foot and Mouth Disease (FMD) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Livestock Foot and Mouth Disease (FMD) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Livestock Foot and Mouth Disease (FMD) Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Livestock Foot and Mouth Disease (FMD) Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Livestock Foot and Mouth Disease (FMD) Vaccines market include Sanofi (Merial), Jinyu Group, Bayer HealthCare, VETAL, VECOL, Tecon Group, Shen Lian, MSD Animal Health and ME VAC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Livestock Foot and Mouth Disease (FMD) Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Livestock Foot and Mouth Disease (FMD) Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Livestock Foot and Mouth Disease (FMD) Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Livestock Foot and Mouth Disease (FMD) Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Company

Sanofi (Merial)

Jinyu Group

Bayer HealthCare

VETAL

VECOL

Tecon Group

Shen Lian

MSD Animal Health

ME VAC

LIMOR

Indian Immunologicals

FGBI

CEVA

Cavet Bio

CAHIC

BVI

Brilliant Bio Pharma

Boehringer Ingelheim

Biogenesis Bagó

BIGVET Biotech

Agrovet

Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Type

Emergency Vaccines

Conventional Vaccines

Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Application

Pig

Cattle

Sheep and Goat

Others

Livestock Foot and Mouth Disease (FMD) Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Livestock Foot and Mouth Disease (FMD) Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Livestock Foot and Mouth Disease (FMD) Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Livestock Foot and Mouth Disease (FMD) Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Livestock Foot and Mouth Disease (FMD) Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Livestock Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Foot and Mouth Disease (FMD) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Livestock Foot and Mouth Disease (FMD) Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Livestock Foot and Mouth Disease (FMD) Vaccines industry.

Chapter 3: Detailed analysis of Livestock Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Livestock Foot and Mouth Disease (FMD) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Livestock Foot and Mouth Disease (FMD) Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Livestock Foot and Mouth Disease (FMD) Vaccines Industry Trends Table 2. Livestock Foot and Mouth Disease (FMD) Vaccines Industry Drivers Table 3. Livestock Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges Table 4. Livestock Foot and Mouth Disease (FMD) Vaccines Industry Restraints Table 5. Global Livestock Foot and Mouth Disease (FMD) Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Livestock Foot and Mouth Disease (FMD) Vaccines Revenue Share by Company (2021-2026) Table 7. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Livestock Foot and Mouth Disease (FMD) Vaccines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Livestock Foot and Mouth Disease (FMD) Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Livestock Foot and Mouth Disease (FMD) Vaccines Company, Product Type & Application Table 13. Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Livestock Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Emergency Vaccines Table 18. Significant Companies of Conventional Vaccines Table 19. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type (2021-2026) Table 28. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pig Table 30. Significant Companies of Cattle Table 31. Significant Companies of Sheep and Goat Table 32. Significant Companies of Others Table 33. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Application (2021-2026) Table 37. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Application (2027-2032) Table 38. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application (2021-2026) Table 42. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application (2027-2032) Table 43. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2026) & (K Units) Table 45. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2021-2026) Table 46. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region (2027-2032) & (K Units) Table 47. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2027-2032) Table 48. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Region (2021-2026) Table 51. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Region (2027-2032) Table 53. Global Livestock Foot and Mouth Disease (FMD) Vaccines Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Livestock Foot and Mouth Disease (FMD) Vaccines Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (K Units) Table 58. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2026) Table 59. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (K Units) Table 60. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2027-2032) Table 61. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Market Share by Country (2021-2026) Table 63. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Market Share by Country (2027-2032) Table 65. Sanofi (Merial) Company Information Table 66. Sanofi (Merial) Business Overview Table 67. Sanofi (Merial) Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Sanofi (Merial) Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 69. Sanofi (Merial) Recent Development Table 70. Jinyu Group Company Information Table 71. Jinyu Group Business Overview Table 72. Jinyu Group Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Jinyu Group Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 74. Jinyu Group Recent Development Table 75. Bayer HealthCare Company Information Table 76. Bayer HealthCare Business Overview Table 77. Bayer HealthCare Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Bayer HealthCare Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 79. Bayer HealthCare Recent Development Table 80. VETAL Company Information Table 81. VETAL Business Overview Table 82. VETAL Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. VETAL Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 84. VETAL Recent Development Table 85. VECOL Company Information Table 86. VECOL Business Overview Table 87. VECOL Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. VECOL Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 89. VECOL Recent Development Table 90. Tecon Group Company Information Table 91. Tecon Group Business Overview Table 92. Tecon Group Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Tecon Group Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 94. Tecon Group Recent Development Table 95. Shen Lian Company Information Table 96. Shen Lian Business Overview Table 97. Shen Lian Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Shen Lian Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 99. Shen Lian Recent Development Table 100. MSD Animal Health Company Information Table 101. MSD Animal Health Business Overview Table 102. MSD Animal Health Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. MSD Animal Health Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 104. MSD Animal Health Recent Development Table 105. ME VAC Company Information Table 106. ME VAC Business Overview Table 107. ME VAC Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. ME VAC Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 109. ME VAC Recent Development Table 110. LIMOR Company Information Table 111. LIMOR Business Overview Table 112. LIMOR Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. LIMOR Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 114. LIMOR Recent Development Table 115. Indian Immunologicals Company Information Table 116. Indian Immunologicals Business Overview Table 117. Indian Immunologicals Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Indian Immunologicals Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 119. Indian Immunologicals Recent Development Table 120. FGBI Company Information Table 121. FGBI Business Overview Table 122. FGBI Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. FGBI Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 124. FGBI Recent Development Table 125. CEVA Company Information Table 126. CEVA Business Overview Table 127. CEVA Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. CEVA Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 129. CEVA Recent Development Table 130. Cavet Bio Company Information Table 131. Cavet Bio Business Overview Table 132. Cavet Bio Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Cavet Bio Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 134. Cavet Bio Recent Development Table 135. CAHIC Company Information Table 136. CAHIC Business Overview Table 137. CAHIC Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. CAHIC Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 139. CAHIC Recent Development Table 140. BVI Company Information Table 141. BVI Business Overview Table 142. BVI Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. BVI Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 144. BVI Recent Development Table 145. Brilliant Bio Pharma Company Information Table 146. Brilliant Bio Pharma Business Overview Table 147. Brilliant Bio Pharma Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Brilliant Bio Pharma Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 149. Brilliant Bio Pharma Recent Development Table 150. Boehringer Ingelheim Company Information Table 151. Boehringer Ingelheim Business Overview Table 152. Boehringer Ingelheim Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Boehringer Ingelheim Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 154. Boehringer Ingelheim Recent Development Table 155. Biogenesis Bagó Company Information Table 156. Biogenesis Bagó Business Overview Table 157. Biogenesis Bagó Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Biogenesis Bagó Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 159. Biogenesis Bagó Recent Development Table 160. BIGVET Biotech Company Information Table 161. BIGVET Biotech Business Overview Table 162. BIGVET Biotech Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. BIGVET Biotech Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 164. BIGVET Biotech Recent Development Table 165. Agrovet Company Information Table 166. Agrovet Business Overview Table 167. Agrovet Livestock Foot and Mouth Disease (FMD) Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Agrovet Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 169. Agrovet Recent Development Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Livestock Foot and Mouth Disease (FMD) Vaccines Distributors List Table 173. Livestock Foot and Mouth Disease (FMD) Vaccines Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Livestock Foot and Mouth Disease (FMD) Vaccines Product Image Figure 2. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Emergency Vaccines Image Figure 10. Conventional Vaccines Image Figure 11. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type (2021-2032) Figure 17. Pig Image Figure 18. Cattle Image Figure 19. Sheep and Goat Image Figure 20. Others Image Figure 21. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Application (2021-2032) Figure 24. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application (2021-2032) Figure 27. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 32. North America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. South America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Livestock Foot and Mouth Disease (FMD) Vaccines Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Emergency Vaccines
  • Conventional Vaccines
Applications
  • Pig
  • Cattle
  • Sheep and Goat
  • Others
Companies covered
  • Sanofi (Merial)
  • Jinyu Group
  • Bayer HealthCare
  • VETAL
  • VECOL
  • Tecon Group
  • Shen Lian
  • MSD Animal Health
  • ME VAC
  • LIMOR
  • Indian Immunologicals
  • FGBI
  • CEVA
  • Cavet Bio
  • CAHIC
  • BVI
  • Brilliant Bio Pharma
  • Boehringer Ingelheim
  • Biogenesis Bagó
  • BIGVET Biotech
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Livestock Foot and Mouth Disease (FMD) Vaccines Market Dynamics
  1. 2.1 Livestock Foot and Mouth Disease (FMD) Vaccines Industry Trends
  2. 2.2 Livestock Foot and Mouth Disease (FMD) Vaccines Industry Drivers
  3. 2.3 Livestock Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges
  4. 2.4 Livestock Foot and Mouth Disease (FMD) Vaccines Industry Restraints
3 Livestock Foot and Mouth Disease (FMD) Vaccines Market by Company
  1. 3.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Livestock Foot and Mouth Disease (FMD) Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Product Type and Application
  8. 3.8 Global Livestock Foot and Mouth Disease (FMD) Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Livestock Foot and Mouth Disease (FMD) Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Livestock Foot and Mouth Disease (FMD) Vaccines Market by Type
  1. 4.1 Livestock Foot and Mouth Disease (FMD) Vaccines Type Introduction
  2. 4.1.1 Emergency Vaccines
  3. 4.1.2 Conventional Vaccines
  4. 4.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type
  5. 4.2.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type
  9. 4.3.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type (2021-2032)
5 Livestock Foot and Mouth Disease (FMD) Vaccines Market by Application
  1. 5.1 Livestock Foot and Mouth Disease (FMD) Vaccines Application Introduction
  2. 5.1.1 Pig
  3. 5.1.2 Cattle
  4. 5.1.3 Sheep and Goat
  5. 5.1.4 Others
  6. 5.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application
  7. 5.2.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application
  11. 5.3.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2021-2032)
  13. 5.3.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application (2021-2032)
6 Livestock Foot and Mouth Disease (FMD) Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Livestock Foot and Mouth Disease (FMD) Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
7 Livestock Foot and Mouth Disease (FMD) Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Livestock Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi (Merial)
  2. 8.1.1 Sanofi (Merial) Company Information
  3. 8.1.2 Sanofi (Merial) Business Overview
  4. 8.1.3 Sanofi (Merial) Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi (Merial) Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  6. 8.1.5 Sanofi (Merial) Recent Developments
  7. 8.2 Jinyu Group
  8. 8.2.1 Jinyu Group Company Information
  9. 8.2.2 Jinyu Group Business Overview
  10. 8.2.3 Jinyu Group Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jinyu Group Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  12. 8.2.5 Jinyu Group Recent Developments
  13. 8.3 Bayer HealthCare
  14. 8.3.1 Bayer HealthCare Company Information
  15. 8.3.2 Bayer HealthCare Business Overview
  16. 8.3.3 Bayer HealthCare Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer HealthCare Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  18. 8.3.5 Bayer HealthCare Recent Developments
  19. 8.4 VETAL
  20. 8.4.1 VETAL Company Information
  21. 8.4.2 VETAL Business Overview
  22. 8.4.3 VETAL Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 VETAL Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  24. 8.4.5 VETAL Recent Developments
  25. 8.5 VECOL
  26. 8.5.1 VECOL Company Information
  27. 8.5.2 VECOL Business Overview
  28. 8.5.3 VECOL Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 VECOL Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  30. 8.5.5 VECOL Recent Developments
  31. 8.6 Tecon Group
  32. 8.6.1 Tecon Group Company Information
  33. 8.6.2 Tecon Group Business Overview
  34. 8.6.3 Tecon Group Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tecon Group Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  36. 8.6.5 Tecon Group Recent Developments
  37. 8.7 Shen Lian
  38. 8.7.1 Shen Lian Company Information
  39. 8.7.2 Shen Lian Business Overview
  40. 8.7.3 Shen Lian Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shen Lian Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  42. 8.7.5 Shen Lian Recent Developments
  43. 8.8 MSD Animal Health
  44. 8.8.1 MSD Animal Health Company Information
  45. 8.8.2 MSD Animal Health Business Overview
  46. 8.8.3 MSD Animal Health Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MSD Animal Health Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  48. 8.8.5 MSD Animal Health Recent Developments
  49. 8.9 ME VAC
  50. 8.9.1 ME VAC Company Information
  51. 8.9.2 ME VAC Business Overview
  52. 8.9.3 ME VAC Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ME VAC Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  54. 8.9.5 ME VAC Recent Developments
  55. 8.10 LIMOR
  56. 8.10.1 LIMOR Company Information
  57. 8.10.2 LIMOR Business Overview
  58. 8.10.3 LIMOR Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 LIMOR Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  60. 8.10.5 LIMOR Recent Developments
  61. 8.11 Indian Immunologicals
  62. 8.11.1 Indian Immunologicals Company Information
  63. 8.11.2 Indian Immunologicals Business Overview
  64. 8.11.3 Indian Immunologicals Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Indian Immunologicals Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  66. 8.11.5 Indian Immunologicals Recent Developments
  67. 8.12 FGBI
  68. 8.12.1 FGBI Company Information
  69. 8.12.2 FGBI Business Overview
  70. 8.12.3 FGBI Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 FGBI Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  72. 8.12.5 FGBI Recent Developments
  73. 8.13 CEVA
  74. 8.13.1 CEVA Company Information
  75. 8.13.2 CEVA Business Overview
  76. 8.13.3 CEVA Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CEVA Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  78. 8.13.5 CEVA Recent Developments
  79. 8.14 Cavet Bio
  80. 8.14.1 Cavet Bio Company Information
  81. 8.14.2 Cavet Bio Business Overview
  82. 8.14.3 Cavet Bio Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Cavet Bio Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  84. 8.14.5 Cavet Bio Recent Developments
  85. 8.15 CAHIC
  86. 8.15.1 CAHIC Company Information
  87. 8.15.2 CAHIC Business Overview
  88. 8.15.3 CAHIC Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CAHIC Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  90. 8.15.5 CAHIC Recent Developments
  91. 8.16 BVI
  92. 8.16.1 BVI Company Information
  93. 8.16.2 BVI Business Overview
  94. 8.16.3 BVI Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 BVI Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  96. 8.16.5 BVI Recent Developments
  97. 8.17 Brilliant Bio Pharma
  98. 8.17.1 Brilliant Bio Pharma Company Information
  99. 8.17.2 Brilliant Bio Pharma Business Overview
  100. 8.17.3 Brilliant Bio Pharma Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Brilliant Bio Pharma Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  102. 8.17.5 Brilliant Bio Pharma Recent Developments
  103. 8.18 Boehringer Ingelheim
  104. 8.18.1 Boehringer Ingelheim Company Information
  105. 8.18.2 Boehringer Ingelheim Business Overview
  106. 8.18.3 Boehringer Ingelheim Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Boehringer Ingelheim Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  108. 8.18.5 Boehringer Ingelheim Recent Developments
  109. 8.19 Biogenesis Bagó
  110. 8.19.1 Biogenesis Bagó Company Information
  111. 8.19.2 Biogenesis Bagó Business Overview
  112. 8.19.3 Biogenesis Bagó Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Biogenesis Bagó Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  114. 8.19.5 Biogenesis Bagó Recent Developments
  115. 8.20 BIGVET Biotech
  116. 8.20.1 BIGVET Biotech Company Information
  117. 8.20.2 BIGVET Biotech Business Overview
  118. 8.20.3 BIGVET Biotech Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 BIGVET Biotech Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  120. 8.20.5 BIGVET Biotech Recent Developments
  121. 8.21 Agrovet
  122. 8.21.1 Agrovet Company Information
  123. 8.21.2 Agrovet Business Overview
  124. 8.21.3 Agrovet Livestock Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Agrovet Livestock Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  126. 8.21.5 Agrovet Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Livestock Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
  2. 9.1.1 Livestock Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Livestock Foot and Mouth Disease (FMD) Vaccines Sales Mode & Process
  6. 9.2 Livestock Foot and Mouth Disease (FMD) Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Livestock Foot and Mouth Disease (FMD) Vaccines Distributors
  9. 9.2.3 Livestock Foot and Mouth Disease (FMD) Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst